NEFL and Sjogren syndrome: Serum NfL (sNfL), as a marker of neuronal cytoskeleton, has shown to increase in the cerebrospinal fluid (CSF) of several neurodegenerative disorders as well as autoimmune inflammatory diseases, including multiple sclerosis, SLE, and primary Sjøgren’s syndrome (17, 53).